Emotional Distress May Confer Worse Immunotherapy Outcomes in NSCLC
Written by
Cancer Network
Published
0
comments
0
min
Prior data from the STRESS-LUNG-1 trial introduced emotional distress as a “psycho-biomarker” for immunotherapy efficacy in non–small cell lung cancer.